277 related articles for article (PubMed ID: 29125193)
1. Exposure to a specific time-varying electromagnetic field inhibits cell proliferation via cAMP and ERK signaling in cancer cells.
Buckner CA; Buckner AL; Koren SA; Persinger MA; Lafrenie RM
Bioelectromagnetics; 2018 Apr; 39(3):217-230. PubMed ID: 29125193
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cancer cell growth by exposure to a specific time-varying electromagnetic field involves T-type calcium channels.
Buckner CA; Buckner AL; Koren SA; Persinger MA; Lafrenie RM
PLoS One; 2015; 10(4):e0124136. PubMed ID: 25875081
[TBL] [Abstract][Full Text] [Related]
3. The effects of electromagnetic fields on B16-BL6 cells are dependent on their spatial and temporal character.
Buckner CA; Buckner AL; Koren SA; Persinger MA; Lafrenie RM
Bioelectromagnetics; 2017 Apr; 38(3):165-174. PubMed ID: 28026051
[TBL] [Abstract][Full Text] [Related]
4. Electromagnetic fields promote osteogenesis of rat mesenchymal stem cells through the PKA and ERK1/2 pathways.
Yong Y; Ming ZD; Feng L; Chun ZW; Hua W
J Tissue Eng Regen Med; 2016 Oct; 10(10):E537-E545. PubMed ID: 24634418
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.
Bidwell P; Joh K; Leaver HA; Rizzo MT
Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):18-29. PubMed ID: 20015475
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of osteogenic differentiation of rat adipose tissue-derived mesenchymal stem cells by zinc sulphate under electromagnetic field via the PKA, ERK1/2 and Wnt/β-catenin signaling pathways.
Fathi E; Farahzadi R
PLoS One; 2017; 12(3):e0173877. PubMed ID: 28339498
[TBL] [Abstract][Full Text] [Related]
7. Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells.
Naviglio S; Di Gesto D; Illiano F; Chiosi E; Giordano A; Illiano G; Spina A
J Cell Physiol; 2010 Nov; 225(3):801-9. PubMed ID: 20589829
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP differentially regulates cell proliferation of normal human keratinocytes through ERK activation depending on the expression pattern of B-Raf.
Takahashi H; Honma M; Miyauchi Y; Nakamura S; Ishida-Yamamoto A; Iizuka H
Arch Dermatol Res; 2004 Jul; 296(2):74-82. PubMed ID: 15278365
[TBL] [Abstract][Full Text] [Related]
9. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
10. Role of the exchange protein directly activated by cyclic adenosine 5'-monophosphate (Epac) pathway in regulating proglucagon gene expression in intestinal endocrine L cells.
Lotfi S; Li Z; Sun J; Zuo Y; Lam PP; Kang Y; Rahimi M; Islam D; Wang P; Gaisano HY; Jin T
Endocrinology; 2006 Aug; 147(8):3727-36. PubMed ID: 16644915
[TBL] [Abstract][Full Text] [Related]
11. Effect of electromagnetic field on cyclic adenosine monophosphate (cAMP) in a human mu-opioid receptor cell model.
Ross CL; Teli T; Harrison BS
Electromagn Biol Med; 2016; 35(3):206-13. PubMed ID: 26151161
[TBL] [Abstract][Full Text] [Related]
12. Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of alpha-difluoromethylornithine in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Jan; 107(1):63-70. PubMed ID: 17333334
[TBL] [Abstract][Full Text] [Related]
13. Regulation of placental leptin expression by cyclic adenosine 5'-monophosphate involves cross talk between protein kinase A and mitogen-activated protein kinase signaling pathways.
Maymó JL; Pérez Pérez A; Dueñas JL; Calvo JC; Sánchez-Margalet V; Varone CL
Endocrinology; 2010 Aug; 151(8):3738-51. PubMed ID: 20484458
[TBL] [Abstract][Full Text] [Related]
14. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.
Yamaguchi T; Nagao S; Wallace DP; Belibi FA; Cowley BD; Pelling JC; Grantham JJ
Kidney Int; 2003 Jun; 63(6):1983-94. PubMed ID: 12753285
[TBL] [Abstract][Full Text] [Related]
16. The effect of electromagnetic fields on the proliferation and the osteogenic or adipogenic differentiation of mesenchymal stem cells modulated by dexamethasone.
Song M; Zhao D; Wei S; Liu C; Liu Y; Wang B; Zhao W; Yang K; Yang Y; Wu H
Bioelectromagnetics; 2014 Oct; 35(7):479-90. PubMed ID: 25145543
[TBL] [Abstract][Full Text] [Related]
17. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
[TBL] [Abstract][Full Text] [Related]
18. Short waves-induced enhancement of proliferation of human chondrocytes: involvement of extracellular signal-regulated map-kinase (erk).
Wang JL; Chan RC; Cheng HH; Huang CJ; Lu YC; Chen IS; Liu SI; Hsu SS; Chang HT; Huang JK; Chen JS; Ho CM; Jan CR
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):581-5. PubMed ID: 17581212
[TBL] [Abstract][Full Text] [Related]
19. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization.
Gros R; Ding Q; Chorazyczewski J; Pickering JG; Limbird LE; Feldman RD
Circ Res; 2006 Oct; 99(8):845-52. PubMed ID: 16973907
[TBL] [Abstract][Full Text] [Related]
20. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
